Progesterone

Progesterone has been studied in 167 papers since 1997: 9 trials and 35 observational studies in people, 29 in animals, 5 in cells, 84 reviews; 69 in the past year. It is an approved medicine. The newest story, Oct 26, 2026: “Progesterone alleviates blood vessel aging in mice”.

InterventionApproved 1974

167 papers study it510 more mention it59 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 68% faster than aging research as a whole: 36 papers in the latest year counted

26 new papers in 30 daysSee all 677 papers on progesterone

At a glance

Progesterone reduces vascular endothelial senescence in ovariectomized mice; human-cell studies report reduced senescence under D-galactose exposure but no clear effect with cigarette smoke extract. One group reports increased muscle protein synthesis in a trial in postmenopausal women. The papers include company-affiliated authors and a declaration of company ties.

59 findings in 42 papers from 2008 to 2026, 11 of them since May 2026

The findings reach people, from one lab or study. 25 independent labs in 15 countries; 149 trials, 6 about aging, 57 with no results posted.

“In postmenopausal women, both T and progesterone treatment increased the muscle protein fractional synthesis rate by approximately 50% (both P<.01)”
Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal womenThe Journal of clinical endocrinology and metabolism2013doi:10.1210/jc.2013-2835

1 of its findings points the other way.

Cells, worms or flies, mice and humans: a single group.
  • 25 independent labs in 15 countries
  • 1 finding against
  • 149 trials, 6 about aging, 57 with no results posted
  • Funders: National Institutes of Health and others
  • 3 of 45 findings with company ties
  • Human trial9
  • Humans35
  • Animals29
  • Cells5
  • In silico1

Studies in people

2 studies gave progesterone to people and measured what changed.

What changedDesignPeopleSource

down: Decreases brachial-ankle pulse wave velocity-0.6 ± 1.4 m/s

Randomized trial12 weeks17 peopleWomen49-75 yearsOlder adults; Postmenopausal women; Patient cohortsClinical hypertension, Sep 15, 2021

up: Increases muscle protein fractional synthesis rateapproximately 50%

up: Increases MYOD1 mRNA expression

Randomized trial24 peopleWomenPostmenopausal women; treatment in postmenopausal womenThe Journal of clinical endocrinology and metabolism, Dec 20, 2013

What did studies of progesterone find?

45

Studies of progesterone measured 45 outcomes; the most studied are oxidative stress and ROS signaling (3 studies), cellular senescence (2) and sleep disturbances (2).

Oxidative stress and ROS signaling

downin human cells1downin rats1downin yeast cells1

3 studies
  1. Progesterone decreases oxidative stress and ROS signaling in human cells (D-galactose-induced senescence).

    “In HAECs, P4 attenuated D-GAL–induced senescence and oxidative stress”

    CellsD-galactose-induced senescencehuman aortic endothelial cell

    Progesterone alleviates blood vessel aging in mice

    ESC Congress 2026 abstract

  2. Progesterone decreases oxidative stress and ROS signaling in yeast cells during chronological aging.

    “resulted in elevated mitochondrial oxygen uptake accompanied by a drop in ROS generation and ATP levels during chronological aging”

    Cellsduring chronological aging

    The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cells

    Microbial cell (Graz, Austria)

  3. Progesterone decreases oxidative stress and ROS signaling in rats (global cerebral ischemia and ovariectomy).

    “estrogens and progesterone or combination of two exert a remarkable neuroprotective effect reducing oxidative stress.”

    Animalsglobal cerebral ischemia and ovariectomybrain72 h of reperfusionfemales

    The effects of 17beta estradiol, 17alpha estradiol and progesterone on oxidative stress biomarkers in ovariectomized female rat brain subjected to global cerebral ischemia

    Physiological research

More on Oxidative stress and ROS signaling

Cellular senescence

downin human cells1no changein human cells1downin mice1

2 studies
  1. Progesterone decreases cellular senescence in human cells (D-galactose-induced senescence).

    “In HAECs, P4 attenuated D-GAL–induced senescence and oxidative stress”

    CellsD-galactose-induced senescencehuman aortic endothelial cell

    Progesterone alleviates blood vessel aging in mice

    ESC Congress 2026 abstract

  2. Progesterone decreases cellular senescence in mice (ovariectomized mice).

    “P4 alleviates ovx-modelled postmenopausal acceleration of vascular endothelial ageing and dysfunction via PR-B–dependent transcriptional repression of KLHL38, thereby preserving SIRT1 protein stability and endothelial homeostasis.”

    Animalsovariectomized micevascular endothelium4 or 8 mg/kg/day6 months

    Progesterone alleviates blood vessel aging in mice

    ESC Congress 2026 abstract

  3. Progesterone showed no clear effect on cellular senescence in human cells (cotreatment with cigarette smoke extract).

    “Progesterone did not reduce OS-induced fetal membrane senescence and SASP.”

    Cellscotreatment with cigarette smoke extractfetal membranes10−6 mol/Ln = 8

    Regulation of p38 mitogen-activated kinase-mediated fetal membrane senescence by statins

    American journal of reproductive immunology (New York, N.Y. : 1989)

More on Cellular senescence

Sleep disturbances

upin humans1downin humans1

2 studies
  1. Progesterone improves sleep disturbances in menopausal females.

    “alleviating vasomotor symptoms and sleep disturbances through its action on GABAergic neurosteroid pathways”

    Reviewin menopausal femalesoral micronized

    Expanding the Horizons of Menopausal Hormone Therapy: A Narrative Review of Progestogen-Only and Testosterone-Only Strategies for Tailored Management

    Journal of menopausal medicine

  2. Progesterone decreases sleep disturbances in humans (menstrual cycle).

    “Progesterone and its metabolites generally have sleep-promoting effects.”

    Reviewmenstrual cyclefemales

    Sleep Disturbances Across a Woman's Lifespan: What Is the Role of Reproductive Hormones?

    Journal of the Endocrine Society

Vasomotor symptoms

upin humans1downin humans1

2 studies
  1. Progesterone improves vasomotor symptoms in menopausal females.

    “robust alternative for alleviating vasomotor symptoms and sleep disturbances”

    Reviewin menopausal femalesoral micronized

    Expanding the Horizons of Menopausal Hormone Therapy: A Narrative Review of Progestogen-Only and Testosterone-Only Strategies for Tailored Management

    Journal of menopausal medicine

  2. Progesterone decreases vasomotor symptoms in perimenopause and menopause.

    “Progesterone therapy during perimenopause and menopause also indirectly leads to healthy ageing through effective treatment of night sweats, hot flushes, and disturbed sleep”

    Reviewin perimenopause and menopausefemales

    Progesterone for reproductive vitality and women’s healthy ageing

    Exploration of Endocrine and Metabolic Diseases

New transcriptional programs

upin humans1

1 study
  1. Progesterone induces new transcriptional programs in humans (estradiol exposure).

    “progesterone preserves half of the estradiol-dependent transcriptional response while inducing new programs”

    Animalsestradiol exposurepatient-derived endometrial xenograft

    Hormone and drug curb growth in human uterine tissue grafts

    iScience

Estradiol-induced proliferation

downin humans1

1 study
  1. Progesterone prevents estradiol-induced proliferation in humans (estradiol exposure).

    “progesterone and BZA prevent estradiol-induced proliferation”

    Animalsestradiol exposurepatient-derived endometrial xenograft

    Hormone and drug curb growth in human uterine tissue grafts

    iScience

Acetylcholine-mediated aortic relaxation

upin mice1

1 study
  1. Progesterone improves acetylcholine-mediated aortic relaxation in mice (ovariectomized mice).

    “P4 dose-dependently reversed these changes.”

    Animalsovariectomized miceaorta4 or 8 mg/kg/day6 months

    Progesterone alleviates blood vessel aging in mice

    ESC Congress 2026 abstract

5-ALPHA-REDUCTASE

downin humans1

1 study
  1. Progesterone inhibits 5-ALPHA-REDUCTASE in humans (menopausal transition).

    “Progesterone withdrawal removes an underappreciated anti-androgenic buffer via competitive 5-alpha-reductase inhibition.”

    Reviewmenopausal transition

    Estrogen, Progesterone, and Testosterone in the Menopausal Transition: Hair Biology, Clinical Consequences, and a Risk-Benefit Framework for Hormonal Assessment and Treatment

    Preprints.orgPreprint

More on 5-ALPHA-REDUCTASE

GFAP

downin mice1

1 study
  1. Progesterone prevents GFAP in MPTP-lesioned OVX mice.

    “Striatal glial fibrillary acidic protein (GFAP), an astrogliosis marker, levels were elevated in MPTP-lesioned mice and this was similarly prevented with the hormonal treatment alone or in combination.”

    Animalsin MPTP-lesioned OVX micestriatum10 daysfemales

    Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease

    Frontiers in neuroscience

More on GFAP

Dopamine loss

downin mice1

1 study
  1. Progesterone prevents dopamine loss in OVX MPTP-lesioned female mice.

    “OVX MPTP-lesioned female mice showed a loss of striatal DA and metabolites content similarly prevented by treatments with raloxifene, progesterone and their combination.”

    Animalsin OVX MPTP-lesioned female micestriatum1 μg, b.i.d.10 daysfemales

    Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease

    Frontiers in neuroscience

More on Dopamine loss

Mammographic density increase

downin humans1

1 study
  1. Progesterone decreases mammographic density increase in humans (combined with estrogen compared with estrogen-only hormone replacement therapy).

    “Postmenopausal women treated with estrogen and progesterone regimens had a statistically significant lesser mammographic density increase than estrogen-only hormone replacement therapy regimens.”

    Human trialcombined with estrogen compared with estrogen-only hormone replacement therapyestrogen plus progesterone regimenbreastfemales

    The Correlation Between Progesterone and Mammographic Density in Postmenopausal Women: A Systematic Review of the Literature and Meta-Analysis

    Cureus

More on Mammographic density increase

Brachial-ankle pulse wave velocity

downin humans1

1 study
  1. Progesterone decreases brachial-ankle pulse wave velocity in humans (combined with percutaneous estradiol gel in postmenopausal grade 1 hypertension) (-0.6 ± 1.4 m/s).

    “Within-group comparisons showed that EPT significantly decreased daytime heart rate and baPWV: the changes from baseline (mean ± standard deviation) were - 2.5 ± 5.7 bpm (P = 0.03) and - 0.6 ± 1.4 m/s (P = 0.04), respectively.”

    Human trialcombined with percutaneous estradiol gel in postmenopausal grade 1 hypertensionmicronized100 mg/d12 weeksfemalesn = 17

    Effects of menopausal hormone therapy on ambulatory blood pressure and arterial stiffness in postmenopausal Korean women with grade 1 hypertension: a randomized, placebo-controlled trial

    Clinical hypertension

More on Brachial-ankle pulse wave velocity

MYOD1 mRNA expression

upin humans1

1 study
  1. Progesterone increases MYOD1 mRNA expression in humans (treatment in postmenopausal women).

    “Progesterone treatment increased MYOD1 mRNA expression (P<.05) but had no effect on MSTN, FST, and FOXO3 mRNA expression.”

    Human trialtreatment in postmenopausal womenskeletal musclefemales

    Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women

    The Journal of clinical endocrinology and metabolism

More on MYOD1 mRNA expression

Muscle protein fractional synthesis rate

upin humans1+50%

1 study
  1. Progesterone increases muscle protein fractional synthesis rate in humans (treatment in postmenopausal women) (approximately 50%).

    “In postmenopausal women, both T and progesterone treatment increased the muscle protein fractional synthesis rate by approximately 50% (both P<.01)”

    Human trialtreatment in postmenopausal womenskeletal musclefemales

    Testosterone and progesterone, but not estradiol, stimulate muscle protein synthesis in postmenopausal women

    The Journal of clinical endocrinology and metabolism

More on Muscle protein fractional synthesis rate

All 45

What is progesterone linked with?

8

Studies link progesterone with 8 measures, among them heart rate variability, cerebello-hippocampal functional connectivity and breast cancer.

Heart rate variability

downin humans1

1 study
  1. Progesterone is associated with heart rate variability in women.

    “progesterone and estrogen withdrawal are linked to reduced vagal modulation and relatively greater sympathetic activation”

    Reviewin womenfemales

    Autonomic Nervous System Regulation in Women: Electrophysiological Signatures of Stress Reactivity across the Female Lifespan

    Neuropsychobiology

More on Heart rate variability

Cerebello-hippocampal functional connectivity

downin humans1

1 study
  1. Progesterone is associated with cerebello-hippocampal functional connectivity in humans.

    “We found lower CB-HP FC with higher levels of progesterone.”

    Humansbrainn = 138

    Age and hormones linked to coordination of brain activity

    Imaging neuroscience (Cambridge, Mass.)

More on Cerebello-hippocampal functional connectivity

Breast cancer

downin humans1

1 study
  1. Progesterone is associated with breast cancer in humans (compared with progestins; observational or case-control evidence).

    “Micronised progesterone and dydrogesterone seem associated with a lower risk of breast cancer than progestins, as shown in observational or case-control studies”

    Reviewcompared with progestins; observational or case-control evidencemicronizedfemales

    Menopausal hormone treatment and breast cancer

    The lancet. Diabetes & endocrinology

More on Breast cancer

Lean mass

upin humans1

1 study
  1. Progesterone is associated with lean mass in humans (independently of age).

    “Independently of age, circulating oestradiol and progesterone, but not testosterone, concentrations were positively associated with lean mass”

    Humansindependently of agefemales

    Profiling muscle mass, function and molecular signalling in females aged 18-80 years and their associations with sex hormones

    The Journal of physiology

Amygdala reactivity

mixedin humans1

1 study
  1. Progesterone is associated with amygdala reactivity in humans (processing of emotional stimuli and memory).

    “Single study-findings suggest an influence of progesterone on amygdala reactivity related to processing of emotional stimuli and memory.”

    Reviewprocessing of emotional stimuli and memoryamygdalafemales

    Progestagens and progesterone receptor modulation: Effects on the brain, mood, stress, and cognition in females

    Frontiers in neuroendocrinology

Cerebellar functional connectivity

downin humans1

1 study
  1. Progesterone is associated with cerebellar functional connectivity in humans.

    “higher progesterone levels were linked to lower connectivity in females.”

    Humanscerebellumfemales

    Sex-steroid hormones relate to cerebellar structure and functional connectivity across adulthood

    bioRxiv : the preprint server for biologyPreprint

Breast cancer risk

mixedin humans1

1 study
  1. Progesterone is associated with breast cancer risk in humans (Compared with progestin-based menopausal hormone therapy in postmenopausal women) (Similar or possibly better profile).

    “P4- versus progestin-based MHT had a similar or possibly better profile for breast cancer and cardiovascular outcomes.”

    ReviewCompared with progestin-based menopausal hormone therapy in postmenopausal womenfemales

    Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Core body temperature

mixedin mice1

1 study
  1. Progesterone is associated with core body temperature in mice.

    “These effects were only partially mimicked by hormonal replacement as Tc was affected by progesterone and to a lesser extent by estrogen but not by testosterone.”

    Animals

    Sex- and age-specific differences in core body temperature of C57Bl/6 mice

    Age (Dordrecht, Netherlands)

More on Core body temperature

Has progesterone been tested in people?

6 of 149 about aging

Yes: 9 trials and 35 observational studies in people have been published, and 147 trials are registered.

Approved

All 9

Repurposing

40 of 81

Every condition in trials

  • Premature Obstetric Labor

    Phase 4Completed5 trials

  • Drug-Induced Abnormalities

    Phase 4Results posted2 trials

  • Helping Behavior

    Phase 4Results posted2 trials

  • IVF

    Phase 4Completed2 trials

  • Risk Reduction Behavior

    Phase 4Results posted2 trials

  • Contraception

    Phase 4Completed1 trial

All 14

Stopped

  • NCT03858049TerminatedInfertility

    The trend in LPS treatment tends to increase the dosage of progesterone in FET-HRT, this study was designed 5 years ago.

  • NCT01286246TerminatedPremature Obstetric Labor

    Trial investigators were unable to recruit the estimated sample

  • NCT03976544TerminatedSpontaneous abortion

    safety

  • NCT00822900TerminatedTraumatic brain injury

    futility: low conditional power to demonstrate benefit of progesterone

  • NCT03202186TerminatedMenopause related conditions

    Inability to recruit subjects

  • NCT02950935TerminatedThreatened abortion in first trimester

    Difficulty in recruitment

All 11

Who is developing progesterone?

3 companies: Merck KGaA, Darmstadt, Germany, Daré Bioscience and Zi Diligence Biocenter.

Companies
  • Merck KGaA, Darmstadt, GermanyPhase 4infertility
  • Daré BiosciencePhase 1pre term birth
  • Zi Diligence BiocenterPhase 1bioequivalance, post-menopause

Trial sponsors

Funding

8 grants since 2016

National Institute on Aging$2MNational Institute of Diabetes and Digestive and Kidney Diseases$2MNational Cancer Institute$726K

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    A mouse study reports that progesterone prevents striatal dopamine loss in ovariectomized, MPTP-lesioned females. A preprint review describes inhibition of 5-alpha-reductase during the human menopausal transition.

  2. Summary written from the findings.

Latest

Dec 2025: 18Jan 2026: 22Feb 2026: 23Mar 2026: 29Apr 2026: 18May 2026: 21Jun 2026: 24Jul 2026: 15Aug 2026: 20Sep 2026: 25Oct 2026: 21Nov 2026: 9245 papers in 12 months
iScience

Hormone and drug curb growth in human uterine tissue grafts

Progesterone preserved half of the gene-activity response to estradiol, while bazedoxifene broadly suppressed estradiol-driven signaling in grafts of human uterine…Progesterone preserved half of the gene-activity response to estradiol, while bazedoxifene broadly suppressed estradiol-driven signaling in grafts of human uterine lining.

Animal studyInterventions
ESC Congress 2026 Abstract

Progesterone alleviates blood vessel aging in mice

Mice with their ovaries removed that received daily progesterone for six months showed dose-dependent reversals of blood vessel cell aging, inflammation, and impaired…Mice with their ovaries removed that received daily progesterone for six months showed dose-dependent reversals of blood vessel cell aging, inflammation, and impaired relaxation.

Mouse studyProgesterone

See all 677 papers on progesterone